Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Rockwell Medical Inc Prices $35.0 Million Public Offering Of Common Stock

Wednesday, 15 May 2013 07:00am EDT 

Rockwell Medical Inc announced that it has priced an underwritten public offering of 11,475,410 shares of its common stock at a price to the public of $3.05 per share for gross proceeds of $35.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Rockwell, will be approximately $32.8 million. Rockwell has also granted the underwriters a 30-day option to purchase up to an additional 1,721,312 shares of common stock offered in the public offering to cover overallotments, if any. The net proceeds of the offering will be used to fund SFP clinical trials and for other general corporate purposes. The offering is expected to close on or about May 20, 2013. Chardan Capital Markets, LLC is acting as the sole book-running manager for the offering. Summer Street Research Partners is acting as lead manager for the offering. C&Co/Prince Ridge LLC is acting as co-manager for the offering. 

Related Company News

Company Quote

0.075 +0.91%
19 Dec 2014